David Kent
Dr. David Kent is a Principal Investigator at the York Biomedical Research Institute (https://www.york.ac.uk/biology/research/infection-immunity/david-kent/). His laboratory's research focuses on the fundamental biology of blood stem cells and how changes in their regulation lead to cancers. David has a long history of public engagement and outreach including the creation of The Black Hole (https://www.universityaffairs.ca/opinion/the-black-hole/) in 2009. He has been writing for Signals since 2010.
Posts by: David
The tiny fingers that touch stem cells
. I was reading Nature the other day and came across a neat article from Yukikio Yamashita’s group at the University of Michigan entitled Nanotubes mediate niche–stem-cell signalling in the Drosophila testis. It may not sound interesting to our average reader, but the cool thing – and presumably what the Nature editors and reviewers enjoyed […]
ISSCR 2015 Stockholm Day 1: RM – learn from nature’s masters…
. I just sat through one of the simplest and most logical talks. Dr. Elly Tanaka, from Heidelberg, took the stage in the plenary session and described an incredible set of data that her lab has generated to understand the molecules involved in limb regeneration – a longstanding dream of the regenerative medicine field. Dr. […]
Stem cell videos – who are they made for? I need reader help…
. Last week the German Stem Cell Network (SCN) released three videos on the current and future possibilities of stem cells. The videos feature three top tier scientists in the field – Andreas Trumpp, Magdalena Gotz and Anthony Ho – and treat viewers to their viewpoints on where stem cell research currently sits and where it is […]
Here we go…cells derived from embryonic stem cells in UK clinics
The United Kingdom has begun its foray into using cells derived from human embryonic stem cells (ESCs) in clinical settings. I have to admit I was surprised that following coverage on the BBC and in The Guardian, there was virtually no anti-ESC protesting to be found, especially considering this was the first human ESC therapy […]